The story of Viagra, and its parent company copyright, presents a challenging case study for investors. Initially a blockbuster drug, generating billions in income, its patent expiration created a flood of lower-priced alternatives , significantly impacting its market share . While some businesses may seek to capitalize on related treatments , the